#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anaemia Leber's congenital amaurosis Endometrial adenocarcinoma Essential thrombocythaemia Cardiac sarcoidosis Infection in an immunocompromised host Asthma Hyperoxaluria Squamous cell carcinoma of the oral cavity Soft tissue sarcoma Bronchopulmonary dysplasia Kearns-Sayre syndrome Polycystic liver disease NTRK gene fusion overexpression Hereditary angioedema More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Basic Information Gastrointestinal stromal tumour Synovial sarcoma recurrent – Basic Information Thrombotic thrombocytopenic purpura – Life with Disease Acquired haemophilia Myelodysplastic syndrome Toxic epidermal necrolysis – Trials in Disease Noonan syndrome – Diagnostics Skin angiosarcoma – Basic Information Haemophagocytic lymphohistiocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000034796 Propofol Ponsegromab Setanaxib Lacosamide Adagrasib Sym024 Regn9933 Wt1 Lamp Mrna Dc Lysine Hydrochloride Valiltramiprosate Nebivolol Hydrochloride Db-1303 Urapidil Azd8630 Tramadol Hydrocortisone Hemisuccinate Ecoo18A Calcitriol Other Immunosuppressants More therapies…

    Learn about Your Condition

    Vascular malformation Genitourinary tract neoplasm Hepatic cirrhosis Hypercholesterolaemia Procedural headache Juvenile spondyloarthritis Fibrosarcoma Thrombocytopenia Bacterial prostatitis Alcoholism Intervertebral disc protrusion Progressive multiple sclerosis Cardiac arrest Peritonitis Gender dysphoria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effectiveness of REGN5668 with Cemiplimab or Ubamatamab for Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal cancer index
    • Ovarian cancer recurrent
    • Fallopian tube cancer
    Investigated Drugs:
    • Regn5668
    • Fianlimab
    • Ubamatamab
    Belgium France Spain

  • Study on the Required Dose of Cholecalciferol for Managing Vitamin D Deficiency in Postmenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Vitamin D deficiency
    Investigated Drugs:
    • Colecalciferol
    Spain

  • Finding the Right Dose of Dobutamine for Very Preterm Infants with Heart and Blood Flow Issues

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Haemodynamic instability
    Investigated Drugs:
    • Dobutamine
    Spain

  • Study on Stopping Anticoagulants in Atrial Fibrillation Patients After Surgery: Warfarin, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Warfarin Sodium
    • Dabigatran
    • Rivaroxaban
    Denmark Sweden

  • Study on Preventing Rejection in Kidney Transplant Patients Using Rabbit Anti-Human Thymocyte Immunoglobulin and Basiliximab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Basiliximab
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    France

  • Study on Immune Markers for Checkpoint Inhibitor Toxicity in Cancer Patients Using Atezolizumab, Dexamethasone Sodium Phosphate, and Alizapride

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Alizapride
    • Cetirizine
    • Pegfilgrastim
    Belgium
Previous Page
1 … 592 593 594 595 596 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!